Summary: In adults (n=117) with coronary artery stenosis located proximal to a myocardial bridge requiring percutaneous coronary intervention, IVUS-guided stent implantation (IGSI) enabling real-time intravascular imaging for accurate stent sizing and positioning demonstrated significantly fewer major adverse cardiac events at 12 months (5.4% vs 18.0%), 100% accurate stent positioning, and complete lesion coverage compared to angiography-guided stent implantation (AGSI) guided solely by fluoroscopic imaging, with no stent extension into the myocardial bridge (vs 32.73% in AGSI).
| PICO | Description |
|---|---|
| Population | Adults (n=117) diagnosed with coronary artery stenosis located proximal to a myocardial bridge requiring percutaneous coronary intervention. |
| Intervention | IVUS-guided stent implantation (IGSI), enabling real-time intravascular imaging for accurate stent sizing and positioning relative to the myocardial bridge. |
| Comparison | Angiography-guided stent implantation (AGSI), guided solely by fluoroscopic imaging without adjunctive intravascular imaging. |
| Outcome | IGSI: MACE 5.4% vs 18.0% at 12 months (P<0.05). Stent positioning: 100% accurate vs 50.91% mispositioned. No stent extension into bridge (vs 32.73%). Complete lesion coverage in all cases. |
Clinical Context
Myocardial bridges (MB) occur when a segment of coronary artery tunnels through the myocardium rather than running on the epicardial surface. The segment proximal to a myocardial bridge is prone to accelerated atherosclerosis due to altered shear stress and disturbed blood flow during cardiac systole. This creates a unique anatomical challenge for percutaneous coronary intervention.
Stenting within or extending into a myocardial bridge is contraindicated due to systolic compression that can cause stent fracture, restenosis, and thrombosis. However, precisely identifying the bridge entrance using angiography alone is difficult because the two-dimensional nature of fluoroscopy cannot reliably visualize the vessel’s relationship to myocardium.
Intravascular ultrasound (IVUS) provides cross-sectional, three-dimensional vessel imaging that visualizes plaque burden, vessel size, and critically, identifies myocardial bridge segments by their characteristic “half-moon” echolucent appearance of overlying myocardium.
Clinical Pearls
1. Dramatic MACE Reduction with IVUS Guidance: The threefold reduction in major adverse cardiac events (5.4% vs 18.0%) argues strongly for mandatory IVUS use when stenting proximal to myocardial bridges.
2. Angiography Alone Fails Half the Time: The 50.91% stent malpositioning rate with angiography guidance reflects a fundamental limitation of two-dimensional imaging for three-dimensional anatomical problems.
3. Bridge Intrusion Is Common and Preventable: Nearly one-third of angiography-guided cases had stent extension into the myocardial bridge. IVUS completely eliminated this problem, which is associated with poor long-term outcomes.
4. Complete Lesion Coverage Achieved with IVUS: IVUS guidance ensured complete lesion coverage in all cases while avoiding bridge intrusion—the optimal balance for this challenging anatomy.
Practical Application
IVUS should be considered standard of care for stenosis proximal to myocardial bridges. Pre-procedure IVUS pullback identifies the bridge entrance and measures true vessel size for stent selection. Post-procedure IVUS confirms appropriate positioning and expansion.
Key IVUS landmark: the “half-moon” echolucent crescent overlying the vessel indicates myocardial bridge. Position the stent to cover all diseased segments while keeping the distal edge at least 2-3 mm proximal to the bridge entrance.
Broader Evidence Context
IVUS guidance for PCI has shown benefits across multiple scenarios including complex lesions, left main disease, and long lesions. Meta-analyses consistently show reduced MACE with IVUS-guided PCI compared to angiography alone. Guidelines increasingly recommend intravascular imaging for complex PCI procedures.
Study Limitations
Relatively small sample size (117 patients) from a single center limits statistical power and generalizability. Non-randomized design introduces potential selection bias. Twelve-month follow-up may not capture late events such as very late stent thrombosis or progressive disease.
Bottom Line
IVUS-guided stent implantation dramatically improves outcomes for lesions proximal to myocardial bridges, reducing MACE from 18% to 5.4% at 12 months while eliminating stent extension into the bridge. Intravascular imaging should be considered mandatory for this indication.
Source: Jia S, et al. “IVUS guiding optimize the outcome of intervention of coronary atherosclerotic stenotic lesions proximal to myocardial bridge.” Medicine (Baltimore), 2025. Read article.
